Speakers of ISM 2022
FMT 2022: Reorganization and Perspective Peter C. Konturek, President of ISM from the Teaching Hospital of the University of Jena, Germany |
Microbiota & Microbiotal Medicine: Where We are Now & What’s Next?Marvin Edeas, Founder & Chairman of ISM, Institut Cochin, INSERM, Université de Paris, France |
Microbiota and Drug Metabolism: Towards a Personalized MedicineCristina Giaroni, University of Insubria, Italy |
|
Christoph Reinhardt, University Mainz, Germany
|
May the Microbiota of the Long-Lived Naked Mole-Rat Affect Human Health?Gerd Birkenmeier, University of Leipzig, Germany |
Understanding the Heterogeneity of Host-associated Microbial CommunitiesLei Dai, Shenzhen Institutes of Advanced Technology, China |
Gut Microbiota-Derived Extracellular Vesicles on Obesity, Diabetes and MetabolismFermin I. Milagro, University of Navarra, Spain |
|
François Leulier, Université de Lyon, France
|
Precision Nutrition to Modulate Gut Microbiota in Reproductive Health and PregnancyAnnalisa Terranegra, Sidra Medical and Research Center, Qatar |
Exploring a Healthy Human Gut Microbiota in a Mediterranean CohortAndrés Moya, University of València, Spain |
Interpreting Microbiomes Via Multi-omics for Precision HealthNathan Price, Thorne HealthTech, USA |
Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated MicrobiotaNicolas Barnich, Université Clermont Auvergne, France
|
Manipulating Fiber Polysaccharide Structure to Alter Targeting to Gut Microbiota Stephen Lindemann, Purdue University, USA |
Short-chain Fatty Acids as Modulators of Redox Signaling in Health and DiseaseCarmen González-Bosch, Universitat de València, Spain |
Proof-of-Principle Demonstration of Endogenous Circadian System and Circadian Misalignment Effects on Human Oral MicrobiotaFrank Scheer, Harvard Medical School, USA |
The Probiotic Strain H. alvei HA4597 for Weight LossPierre Déchelotte, Rouen Normandy University, France |
Probiotics and FMT as Add-On Therapies for DepressionAndré Schmidt, University of Basel, Switzerland |
Oral Microbial Dysbiosis and Oral DiseasesXin Xu, Sichuan University, China |
Microbial Biomarkers to Predict Respiratory InfectionClaire A. Woodall, University of Bristol, United Kingdom |
| Matteo Serino, CRCN INSERM, France |
|
Maria Cecilia Giron, University of Padova, Italy |
| Jarosław Biliński, Medical University of Warsaw, Poland |
|
Benoit Chassaing, Institut Cochin, France
|
|
|
Influence of the Gut Microbiome in Ischemic Stroke Risk and Ischemic Stroke OutcomeMiquel Lledós, Biomedical Research Institute Sant Pau, Spain |
|
Emrah Altindis, Biology Department Boston College, USA
|
Gene Editing and Microbiome TherapyNahla Mansour, National Reseacrh Center, Egypt |
Vaginal Microbiota and Dysbiosis: Recent Advances and PerspectiveGary Ventolini, Texas Tech University Health Sciences Center, USA |
|
Sebastian Granica, Medical University of Warsaw, Poland
|



Microbiota & Microbiotal Medicine: Where We are Now & What’s Next?
















Host-Microbes Mechanisms during E. coli Infections and Diet-induced Dysmetabolism
Cancer Therapy and Microbiota
Fecal Microbiota Transplantation as an Immunomodulatory and Anti-Infective Agent


A Gut Commensal, Parabacteroides distasonis, and Type 1 Diabetes Onset










































